NFE2L2 and cancer: Although additional studies are required to better characterize the toxicity profile as well as the efficacy of these agents in specific clinical contexts, there is undisputable evidence that these compounds hold great promises in the treatment of malignant tumors, particularly in those cancer types with Nrf2 aberrant expression.